Company / Interest Expense
Caris Life Sciences, Inc. Interest Expense History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$56.8M
FY2025
5-year range
$31.5M / $56.8M
FY2023-FY2025
Trend
+13.7%
vs FY2024
Sector context
#25 of 46
Health Care
What the data says
At $57M, Caris Life Sciences, Inc.'s interest expense ranks #22 of 46 in the Health Care sector. Increased from $32M to $57M over the past 2 years.
Based on SEC 10-K filings.
$57M in FY2025.
Increased from $32M to $57M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#22 of 46 in Health CareTop 46% of 46This company $56.8M Sector average $293.8M
▼
-80.7% below sector average
Key checks
Key Insights
- In FY2025, interest expense increased 13.7% year-over-year.
- Ranks #25 out of 46 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $56.8M | +13.7% |
| FY2024 | $50.0M | +58.5% |
| FY2023 | $31.5M | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026